Health and Healthcare

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

250 Articles

Chris Lange | Sep 25, 2020 at 9:54 AM EDT

Biotech Short Sellers Hike Their Bets

The September 15 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Sep 11, 2020 at 10:05 AM EDT

Short Sellers Hike Their Bets in Major Biotechs

The August 31 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Aug 26, 2020 at 10:13 AM EDT

Major Biotechs Scare Off Short Sellers

The August 14 short interest data has been compared with the previous report, and short interest in most of these…

Lee Jackson | Jul 30, 2020 at 7:26 AM EDT

Jefferies Has 10 Stocks to Buy Now That Could Beat Q2 Earnings Estimates

Jefferies analysts have named 10 companies they think have a solid chance of posting second-quarter results that exceed current Wall…

Douglas A. McIntyre | Jul 29, 2020 at 6:30 AM EDT

These Are the Only 4 S&P 500 Companies Run by Women of Color

About nine in 10 CEOs at S&P 500 companies are white men. There are only four female chief executives of…

Chris Lange | Jul 26, 2020 at 6:31 AM EDT

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Earnings season is in full swing, and we have put together a preview of some of the world’s largest players…

Chris Lange | Jul 24, 2020 at 10:51 AM EDT

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

Goldman Sachs has seven biopharma stocks on its Conviction Buy list, and these are not all coronavirus plays. The firm…

Jon C. Ogg | Jul 8, 2020 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Citigroup, Disney, Endo, JPMorgan, Livongo, Nikola, Nokia, Novavax, Transocean, Valero and More

Wednesday's top analyst upgrades and downgrades included Altria, Apple, Caterpillar, Citigroup, JPMorgan, Nikola, Nokia, Novavax, Transocean, Valero Energy, Walt Disney…

Jon C. Ogg | May 19, 2020 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Beyond Meat, BioNTech, Comcast, DraftKings, Expedia, Gap, Gilead, Hess, Lululemon, Newmont, Royal Gold and More

Tuesday's top analyst upgrades and downgrades included Beyond Meat, BioNTech, Comcast, DraftKings, Expedia, Gap, Gilead Sciences, Hess, Lululemon Athletica, Newmont…

Lee Jackson | May 11, 2020 at 7:24 AM EDT

5 Top Health Care Stocks to Buy Now on the Goldman Sachs Conviction List

These are five of the best stocks in a sector that has been humming along in what has been a…

Jon C. Ogg | Apr 30, 2020 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Carvana, Caterpillar, Dollar General, DraftKings, eBay, Facebook, Microsoft, Schlumberger, Spotify, Tesla and More

Thursday's top analyst upgrades and downgrades included Carvana, Caterpillar, Dollar General, DraftKings, eBay, Facebook, Microsoft, Schlumberger, Spotify and Tesla.

Jon C. Ogg | Apr 28, 2020 at 9:02 AM EDT

Top Analyst Upgrades and Downgrades: AT&T, Cognex, Disney, J&J, Keurig Dr Pepper, PayPal, Roku, Shopify, Square, Valero and More

Tuesday's top analyst upgrades and downgrades included AT&T, Cognex, Johnson & Johnson, Keurig Dr Pepper, PayPal, Roku, Shopify, Square, Valero…

Lee Jackson | Apr 27, 2020 at 7:15 AM EDT

Goldman Sachs Says Buy 4 Biotech Stocks in Front of Q1 Earnings

Goldman Sachs analysts are bullish on these four top biotech stocks in front of first-quarter results. None of these companies…

Jon C. Ogg | Jan 30, 2020 at 5:35 PM EST

7 Major After-Hours Movers on Thursday

Companies like IBM, Amazon, Western Digital and EA all posted big moves, some far more than what was expected, in…

Chris Lange | Jan 23, 2020 at 1:35 PM EST

How Earnings Will Dictate Biotech Sector’s Fate in 2020

Why Credit Suisse believes that this round of quarterly biotech earnings could prove to be a catalyst for 2020.

1 2 3 4 5 6 … 17

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

Biotech Short Sellers Hike Their Bets

Short Sellers Hike Their Bets in Major Biotechs

Major Biotechs Scare Off Short Sellers

Jefferies Has 10 Stocks to Buy Now That Could Beat Q2 Earnings Estimates

These Are the Only 4 S&P 500 Companies Run by Women of Color

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

Top Analyst Upgrades and Downgrades: Apple, Citigroup, Disney, Endo, JPMorgan, Livongo, Nikola, Nokia, Novavax, Transocean, Valero and More

Top Analyst Upgrades and Downgrades: Beyond Meat, BioNTech, Comcast, DraftKings, Expedia, Gap, Gilead, Hess, Lululemon, Newmont, Royal Gold and More

5 Top Health Care Stocks to Buy Now on the Goldman Sachs Conviction List

Top Analyst Upgrades and Downgrades: Carvana, Caterpillar, Dollar General, DraftKings, eBay, Facebook, Microsoft, Schlumberger, Spotify, Tesla and More

Top Analyst Upgrades and Downgrades: AT&T, Cognex, Disney, J&J, Keurig Dr Pepper, PayPal, Roku, Shopify, Square, Valero and More

Goldman Sachs Says Buy 4 Biotech Stocks in Front of Q1 Earnings

7 Major After-Hours Movers on Thursday

How Earnings Will Dictate Biotech Sector’s Fate in 2020

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Warren Buffett’s Parting Gift to Investors Is Crushing the Market 6 Months Later

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

College-Educated Families Earned $242,200 While Others Made $42,200, Here's Why the Gap Widened

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

Biotech Short Sellers Hike Their Bets

Short Sellers Hike Their Bets in Major Biotechs

Major Biotechs Scare Off Short Sellers

Jefferies Has 10 Stocks to Buy Now That Could Beat Q2 Earnings Estimates

These Are the Only 4 S&P 500 Companies Run by Women of Color

AbbVie, Eli Lilly, Gilead, and More Biopharma Stocks Reporting Earnings This Week

Goldman Sachs Sees Big Gains From 7 Biotech & Pharma Conviction Buy Stocks

Top Analyst Upgrades and Downgrades: Apple, Citigroup, Disney, Endo, JPMorgan, Livongo, Nikola, Nokia, Novavax, Transocean, Valero and More

Top Analyst Upgrades and Downgrades: Beyond Meat, BioNTech, Comcast, DraftKings, Expedia, Gap, Gilead, Hess, Lululemon, Newmont, Royal Gold and More

5 Top Health Care Stocks to Buy Now on the Goldman Sachs Conviction List

Top Analyst Upgrades and Downgrades: Carvana, Caterpillar, Dollar General, DraftKings, eBay, Facebook, Microsoft, Schlumberger, Spotify, Tesla and More

Top Analyst Upgrades and Downgrades: AT&T, Cognex, Disney, J&J, Keurig Dr Pepper, PayPal, Roku, Shopify, Square, Valero and More

Goldman Sachs Says Buy 4 Biotech Stocks in Front of Q1 Earnings

7 Major After-Hours Movers on Thursday

How Earnings Will Dictate Biotech Sector’s Fate in 2020

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Warren Buffett’s Parting Gift to Investors Is Crushing the Market 6 Months Later

Featured Reads

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

College-Educated Families Earned $242,200 While Others Made $42,200, Here's Why the Gap Widened